spacer
home > pmps > spring 2018 > digital double-win
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Digital Double-Win

Today’s pharmaceutical executives navigate extremely complex territory on a daily basis. The toughest quandary they face is existential in nature: how to survive and thrive in the digital economy. Digital developments present both risks – including those connected with business, security, and compliance – and tremendous upside performance transformation opportunities.

Industry headlines are forcing executives to think long and hard about their digital transformation strategies. Consider these sample, thought-provoking headlines:

• Why did CVS buy Aetna for $69 billion? (1)
• Mylan and Teva stocks rise on report about Amazon’s pharmacy aims (2)
• Hearing Amazon’s footsteps, the healthcare industry shudders (3)
• Big Pharma builds blockchain prototype to stop counterfeits (4)
• FDA pushes DSCSA serialisation enforcement deadline to 2018 (5)
• Pharma’s digital supply chain transformation (6)

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

 You must be a member of the site to make a comment.
spacer
Evren Ozkaya PhD is the Founder and CEO of Supply Chain Wizard: a full-service global consulting firm specialising in serialisation and traceability as well as supply chain strategy and operational transformation programmes. Supply Chain Wizard offers products and services targeting serialisation and supply chain transformation initiatives, along with a team of consultants providing comprehensive support towards cost-effective compliance with serialisation mandates and post-go-live operational support. Email:
spacer
Dr Evren Ozkaya
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

New to the PPMA Show 2018: Bright Ideas - Ambassador Programme

A new initiative for PPMA Show visitors this year is the Bright Ideas - Ambassador Programme - a free advice service for start-up ventures and entrepreneurs.
More info >>

White Papers

pAVEway™ expression system for the efficient expression of therapeutic proteins

Fujifilm Diosynth Biotechnologies

One of the major bottlenecks in the production of biopharmaceuticals is the efficient expression of therapeutic proteins in microbial or mammalian cells. The Escherichia coli pAVEway™ expression system described here has been developed to ensure high product titres and efficient scale up to GMP manufacture, whilst minimising many common issues seen in other expression systems, such as ‘leaky’ expression (expression of recombinant protein in the absence of inducer).
More info >>

 
Industry Events

Synthetic Biology Congress

8-9 November 2018, London, UK

Oxford Global is proud to present its Synthetic Biology Congress taking place on 8-9 November 2018 in London. As part of our Genomics and Synthetic Biology UK series, our congress will bring together Over 600 delegates representing internationally renowned research & academic institutions, clinical research institutions and pharmaceutical companies.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement